An inside look at GRAIL, the California healthcare firm bringing hundreds of jobs to RTP

GRAIL, a 5-year-old Menlo Park company whose mission is “to detect cancer early, when it can be cured,” has raised more than $2 billion in venture capital to support its development of a “liquid biopsy” blood test to detect more than 50 types of cancers in people, even before they develop symptoms. Now the company is expanding to North Carolina. Here’s a look at the firm.

Read More